Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

3 results
Display

Single Nucleotide Polymorphisms of Toll-Like Receptor 7 and Toll-Like Receptor 9 in Hepatitis C Virus Infection Patients from Central China

Wei XS, Wei CD, Tong YQ, Zhu CL, Zhang PA

  • KMID: 2386473
  • Yonsei Med J.
  • 2014 Mar;55(2):428-434.
PURPOSE: To analyze the correlation of polymorphisms of toll-like receptor 7 (TLR7) (rs179009) and toll-like receptor 9 (TLR9) (rs187084) in hepatitis C virus (HCV) infections in the Han population. MATERIALS AND...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Basal Cell Carcinoma Treated with Combination of CO2 Laser and 5% Imiquimod Cream

Kwon YH, Nam JH, Kim TH, Lee GY, Kim WS, Kim KJ

  • KMID: 2248786
  • Korean J Dermatol.
  • 2007 Nov;45(11):1187-1190.
Basal cell carcinoma is the most common skin cancer and surgical treatments like Mohs surgery have been accepted as ideal for it. Although surgical treatments are very effective, non-invasive treatments...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effects of 5% Imiquimod Cream on Bowen's Disease

Ko HC, Oh CK, Kim SJ, Kim BS, Jang BS, Kim MB, Kwon KS

  • KMID: 2248900
  • Korean J Dermatol.
  • 2006 Dec;44(12):1410-1416.
BACKGROUND: Imiquimod is an immune response modifier which works as a Toll-like receptor 7 agonist which induces interferon and other cytokines through the innate immune system and stimulates cell-mediated immunity...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr